2m 2m 2m 2m 2m 2m 2m
SOLIGENIX (SNGX)
NASDAQ
$0.52-$0.23 (-31.22%)
Price as of Jun 03, 2026 6:51 PM EDT- $13.5MMarket Cap
- -61.60%1-Year Change
- BiotechnologyIndustry
SOLIGENIX (SNGX)
$0.52-$0.23 (-31.22%)
SNGX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.75 | ||
Change | -$0.08 (-9.27%) | ||
Open | $0.76 | ||
High | $0.81 | ||
Low | $0.73 | ||
Previous Close | $0.83 | ||
Volume | 4,734,042 | ||
30-Day Average Volume | 19,239,615 | ||
1-Week Change | 45.96% | ||
1-Month Change | 117.04% | ||
1-Year Change | -61.60% | ||
3-Year Change | -93.50% | ||
5-Year Change | -99.69% | ||
Fundamentals | |||
Shares Outstanding | 14.8M | ||
Total Assets | $6.9M | ||
Market Cap | $13.5M | ||
Enterprise Value | $7.5M | ||
Period: QTR TTM FY | |||
Revenue | $1.1M | ||
Net Income | -$2.8M | ||
Free Cash Flow | -$2.4M | ||
EBIT | -$2.8M | ||
EBITDA | -$2.8M | ||
Net Working Capital | $2.9M | ||
EPS | -$0.28 | ||
Enterprise Value/EBITDA | -3 | ||
Enterprise Value/Revenue | 7 | ||
P/B | 4 | ||
P/E | -3 | ||
PEG | 0 | ||
Price/Free Cash Flow | -6 | ||
Price/Operating Cash Flow | -6 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 16 | ||
Last Split Date | 06/06/2024 | ||
Earnings & Revenue